{"product_id":"tesamorelin","title":"Tesamorelin 10mg Pen","description":"\u003cdiv class=\"otQkpb\" role=\"heading\"\u003e\n\u003cstrong\u003eUnderstanding Tesamorelin: The Visceral Fat Reduction Solution\u003c\/strong\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"n6owBd awi2gc\"\u003e\n\u003cstrong class=\"rQesXe MPyX\"\u003eProduct Strength:\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e 2mg \/ 6mg per vial (commonly reconstituted with Bacteriostatic Water or provided in multi-dose delivery systems)\u003cspan\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"n6owBd awi2gc\"\u003e\n\u003cstrong class=\"rQesXe MPyX\"\u003eStorage:\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e Prior to reconstitution, store lyophilized powder in the refrigerator between 2–8 °C or at controlled room temperature up to 25 °C. After reconstitution, \u003cstrong class=\"rQesXe MPyX\"\u003ekeep refrigerated between 2–8 °C\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e and use within the manufacturer's specified timeframe (typically 24 hours to 14 days depending on the formulation) to maintain potency and stability. Protect from light.\u003cspan\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"n6owBd awi2gc\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv class=\"yhAwj\"\u003e\u003c!--TgQPHd|||[]--\u003e\u003c\/div\u003e\n\u003cdiv class=\"otQkpb\" role=\"heading\"\u003e\n\u003cstrong\u003eWhat It Is\u003c\/strong\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"n6owBd awi2gc\"\u003e\n\u003cstrong class=\"rQesXe MPyX\"\u003eTesamorelin\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e (as tesamorelin acetate) is a synthetic peptide consisting of 44 amino acids. It is a stabilized analogue of \u003cstrong class=\"rQesXe MPyX\"\u003eGrowth Hormone-Releasing Hormone (GHRH)\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e, modified with an anchoring hexenoyl group at its N-terminal tyrosine to enhance its stability, metabolic half-life, and resistance to enzymatic degradation compared to natural GHRH.\u003cspan\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"n6owBd awi2gc\"\u003eThe clinical development of Tesamorelin stemmed from the critical need to address metabolic complications observed in HIV-infected patients undergoing highly active antiretroviral therapy (HAART). In November 2010, the U.S. Food and Drug Administration (FDA) approved tesamorelin under the brand name Egrifta® to reduce excess abdominal fat in HIV-infected patients with lipodystrophy.\u003cspan\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"n6owBd awi2gc\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv class=\"yhAwj\"\u003e\u003c!--TgQPHd|||[]--\u003e\u003c\/div\u003e\n\u003cdiv class=\"otQkpb\" role=\"heading\"\u003e\n\u003cstrong\u003eMechanism of Action\u003c\/strong\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"n6owBd awi2gc\"\u003eTesamorelin functions as a selective agonist at growth hormone-releasing hormone receptors (GHRHR) in the anterior pituitary gland. Unlike recombinant human growth hormone (rhGH), which causes unnatural, pulsatile-shattering spikes in systemic GH, Tesamorelin stimulates the pituitary to secrete growth hormone in a more physiological, \u003cstrong class=\"rQesXe MPyX\"\u003epulsatile manner\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e.\u003cspan\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"n6owBd awi2gc\"\u003eOnce released, growth hormone travels to the liver and peripheral tissues to stimulate the synthesis and secretion of Insulin-like Growth Factor 1 (IGF-1). The combined elevation of GH and IGF-1 drives downstream lipolytic pathways. GH binds directly to adipocytes, activating hormone-sensitive lipase (HSL) and promoting lipolysis—the breakdown of stored triglycerides into free fatty acids. This effect is exceptionally pronounced in \u003cstrong class=\"rQesXe MPyX\"\u003evisceral adipose tissue (VAT)\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e, which possesses a higher density of GHRH receptors and a greater sensitivity to lipolytic stimuli compared to subcutaneous fat.\u003cspan\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"yhAwj\"\u003e\u003c!--TgQPHd|||[]--\u003e\u003c\/div\u003e\n\u003cdiv class=\"otQkpb\" role=\"heading\"\u003e\n\u003cstrong\u003e\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"otQkpb\" role=\"heading\"\u003e\n\u003cstrong\u003eKey Research Applications \u0026amp; Uses\u003c\/strong\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"yhAwj\"\u003e\u003c!--TgQPHd|||[]--\u003e\u003c\/div\u003e\n\u003cdiv class=\"AdPoic\" role=\"heading\"\u003eFDA-Approved Indication:\u003cspan\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/div\u003e\n\u003cul class=\"KsbFXc U6u95\"\u003e\n\u003cli class=\"Z1qcYe\"\u003e\n\u003cspan class=\"iNqyIf\"\u003e\u003cstrong class=\"rQesXe MPyX\"\u003eHIV-Associated Lipodystrophy:\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e Tesamorelin is specifically indicated for the reduction of excess visceral abdominal fat in HIV-infected patients suffering from lipodystrophy. Visceral fat is the deep, dangerous fat surrounding internal organs that increases cardiovascular and metabolic risks.\u003c!--TgQPHd|||[]--\u003e\u003c\/span\u003e\u003cspan\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/li\u003e\n\u003c!--TgQPHd|||[]--\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"yhAwj\"\u003e\u003c!--TgQPHd|||[]--\u003e\u003c\/div\u003e\n\u003cdiv class=\"AdPoic\" role=\"heading\"\u003eOff-Label \u0026amp; Research Uses:\u003cspan\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/div\u003e\n\u003cul class=\"KsbFXc U6u95\"\u003e\n\u003cli class=\"Z1qcYe\"\u003e\n\u003cspan class=\"iNqyIf\"\u003e\u003cstrong class=\"rQesXe MPyX\"\u003eNon-HIV Visceral Adiposity:\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e It is studied for its ability to target deep, stubborn abdominal fat in individuals without HIV who suffer from metabolic syndrome or severe central obesity.\u003c!--TgQPHd|||[]--\u003e\u003c\/span\u003e\u003cspan\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/li\u003e\n\u003cli class=\"Z1qcYe\"\u003e\n\u003cspan class=\"iNqyIf\"\u003e\u003cstrong class=\"rQesXe MPyX\"\u003eNon-Alcoholic Fatty Liver Disease (NAFLD\/NASH):\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e Clinical studies have demonstrated that Tesamorelin significantly reduces liver fat content, offering a potential therapeutic avenue for reversing early-stage fatty liver disease.\u003c!--TgQPHd|||[]--\u003e\u003c\/span\u003e\u003cspan\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/li\u003e\n\u003cli class=\"Z1qcYe\"\u003e\n\u003cspan class=\"iNqyIf\"\u003e\u003cstrong class=\"rQesXe MPyX\"\u003eAge-Related Growth Hormone Decline:\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e The peptide is evaluated in anti-aging and regenerative medicine protocols to naturally restore declining growth hormone levels in older adults.\u003c!--TgQPHd|||[]--\u003e\u003c\/span\u003e\u003cspan\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/li\u003e\n\u003cli class=\"Z1qcYe\"\u003e\n\u003cspan class=\"iNqyIf\"\u003e\u003cstrong class=\"rQesXe MPyX\"\u003eCognitive Optimization:\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e Early clinical research suggests that GHRH analogues may improve executive function and mild cognitive impairment in older individuals by enhancing cerebral blood flow and neuroprotection.\u003c!--TgQPHd|||[]--\u003e\u003c\/span\u003e\u003cspan\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/li\u003e\n\u003cli class=\"Z1qcYe\"\u003e\n\u003cspan class=\"iNqyIf\"\u003e\u003cstrong class=\"rQesXe MPyX\"\u003eLean Body Mass Preservation:\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e Due to the anabolic nature of elevated growth hormone and IGF-1, research explores its capacity to support lean muscle maintenance during targeted fat loss phases.\u003c!--TgQPHd|||[]--\u003e\u003c\/span\u003e\u003cspan\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/li\u003e\n\u003c!--TgQPHd|||[]--\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"yhAwj\"\u003e\u003c!--TgQPHd|||[]--\u003e\u003c\/div\u003e\n\u003cdiv class=\"otQkpb\" role=\"heading\"\u003e\n\u003cstrong\u003eAdministration \u0026amp; Dosage\u003c\/strong\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"n6owBd awi2gc\"\u003eTesamorelin is administered via subcutaneous injection, usually into the abdominal region, avoiding scar tissue, bruising, or the navel.\u003cspan\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/div\u003e\n\u003cul class=\"KsbFXc U6u95\"\u003e\n\u003cli class=\"Z1qcYe\"\u003e\n\u003cspan class=\"iNqyIf\"\u003e\u003cstrong class=\"rQesXe MPyX\"\u003eTiming:\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e Administered once daily, typically in the morning or before bedtime on an empty stomach to optimize natural growth hormone secretion patterns.\u003c!--TgQPHd|||[]--\u003e\u003c\/span\u003e\u003cspan\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/li\u003e\n\u003cli class=\"Z1qcYe\"\u003e\n\u003cspan class=\"iNqyIf\"\u003e\u003cstrong class=\"rQesXe MPyX\"\u003eFrequency:\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e Standard clinical dosing for approved indications is a daily subcutaneous injection. Continuous monitoring of IGF-1 levels is recommended during long-term therapy.\u003c!--TgQPHd|||[]--\u003e\u003c\/span\u003e\u003cspan\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/li\u003e\n\u003c!--TgQPHd|||[]--\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"yhAwj\"\u003e\u003c!--TgQPHd|||[]--\u003e\u003c\/div\u003e\n\u003cdiv class=\"AdPoic\" role=\"heading\"\u003e\n\u003cstrong\u003eOnset \u0026amp; Duration:\u003c\/strong\u003e\u003cspan\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/div\u003e\n\u003cul class=\"KsbFXc U6u95\"\u003e\n\u003cli class=\"Z1qcYe\"\u003e\n\u003cspan class=\"iNqyIf\"\u003e\u003cstrong class=\"rQesXe MPyX\"\u003eOnset:\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e Changes in systemic growth hormone levels occur rapidly within hours of injection. However, visible reductions in visceral fat require consistent daily compliance.\u003c!--TgQPHd|||[]--\u003e\u003c\/span\u003e\u003cspan\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/li\u003e\n\u003cli class=\"Z1qcYe\"\u003e\n\u003cspan class=\"iNqyIf\"\u003e\u003cstrong class=\"rQesXe MPyX\"\u003eDuration:\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e Noticeable improvements in body composition typically present within 12 to 26 weeks of continuous therapy. Visceral fat accumulation generally recurs if the medication is discontinued.\u003c!--TgQPHd|||[]--\u003e\u003c\/span\u003e\u003cspan\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/li\u003e\n\u003c!--TgQPHd|||[]--\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"yhAwj\"\u003e\u003c!--TgQPHd|||[]--\u003e\u003c\/div\u003e\n\u003cdiv class=\"otQkpb\" role=\"heading\"\u003e\n\u003cstrong\u003eContraindications \u0026amp; Precautions\u003c\/strong\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"n6owBd awi2gc\"\u003eTesamorelin is \u003cstrong class=\"rQesXe MPyX\"\u003econtraindicated\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e in individuals with the following conditions:\u003cspan\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/div\u003e\n\u003cul class=\"KsbFXc U6u95\"\u003e\n\u003cli class=\"Z1qcYe\"\u003e\n\u003cspan class=\"iNqyIf\"\u003e\u003cstrong class=\"rQesXe MPyX\"\u003eActive Malignancy or Cancer History:\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e Growth hormone and IGF-1 promote cellular proliferation. Any active malignancy or history of cancer is a strict contraindication.\u003c!--TgQPHd|||[]--\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/li\u003e\n\u003cli class=\"Z1qcYe\"\u003e\n\u003cspan class=\"iNqyIf\"\u003e\u003cstrong class=\"rQesXe MPyX\"\u003ePregnancy and Lactation:\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e Tesamorelin can cause fetal harm and is contraindicated during pregnancy. It should be discontinued immediately if pregnancy occurs.\u003c!--TgQPHd|||[]--\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/li\u003e\n\u003cli class=\"Z1qcYe\"\u003e\n\u003cspan class=\"iNqyIf\"\u003e\u003cstrong class=\"rQesXe MPyX\"\u003eDisruption of the Hypothalamic-Pituitary Axis:\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e Patients with pituitary tumors, hypophysectomy, or intracranial radiation therapy should not use this peptide.\u003c!--TgQPHd|||[]--\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/li\u003e\n\u003cli class=\"Z1qcYe\"\u003e\n\u003cspan class=\"iNqyIf\"\u003e\u003cstrong class=\"rQesXe MPyX\"\u003eHypersensitivity:\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e Known allergy to tesamorelin, mannitol, or any structural component of the injection formulation.\u003c!--TgQPHd|||[]--\u003e\u003c\/span\u003e\u003cspan\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/li\u003e\n\u003c!--TgQPHd|||[]--\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"yhAwj\"\u003e\u003c!--TgQPHd|||[]--\u003e\u003c\/div\u003e\n\u003cdiv class=\"otQkpb\" role=\"heading\"\u003e\n\u003cstrong\u003eAdverse Reactions \u0026amp; Side Effects\u003c\/strong\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"n6owBd awi2gc\"\u003eThe most common side effects associated with Tesamorelin are generally mild to moderate, primarily related to increased growth hormone levels and fluid retention:\u003cspan\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/div\u003e\n\u003cul class=\"KsbFXc U6u95\"\u003e\n\u003cli class=\"Z1qcYe\"\u003e\n\u003cspan class=\"iNqyIf\"\u003e\u003cstrong class=\"rQesXe MPyX\"\u003eArthralgia and Myalgia:\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e Joint pain and muscle aches occur in roughly 13–14% of users due to fluid shifts in tissue space.\u003c!--TgQPHd|||[]--\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/li\u003e\n\u003cli class=\"Z1qcYe\"\u003e\n\u003cspan class=\"iNqyIf\"\u003e\u003cstrong class=\"rQesXe MPyX\"\u003eInjection Site Reactions:\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e Redness, swelling, itching, or pain at the site of injection, affecting up to 12% of users.\u003c!--TgQPHd|||[]--\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/li\u003e\n\u003cli class=\"Z1qcYe\"\u003e\n\u003cspan class=\"iNqyIf\"\u003e\u003cstrong class=\"rQesXe MPyX\"\u003ePeripheral Edema:\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e Swelling in the hands, feet, or lower legs caused by mild fluid retention.\u003c!--TgQPHd|||[]--\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/li\u003e\n\u003cli class=\"Z1qcYe\"\u003e\n\u003cspan class=\"iNqyIf\"\u003e\u003cstrong class=\"rQesXe MPyX\"\u003eParesthesia and Carpal Tunnel Symptoms:\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e Numbness, tingling, or stiffness in fingers and extremities.\u003c!--TgQPHd|||[]--\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/li\u003e\n\u003cli class=\"Z1qcYe\"\u003e\n\u003cspan class=\"iNqyIf\"\u003e\u003cstrong class=\"rQesXe MPyX\"\u003eGlucose Intolerance:\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e Transient increases in blood sugar or HbA1c can occur; growth hormone naturally antagonizes insulin action.\u003c!--TgQPHd|||[]--\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/li\u003e\n\u003cli class=\"Z1qcYe\"\u003e\n\u003cspan class=\"iNqyIf\"\u003e\u003cstrong class=\"rQesXe MPyX\"\u003eNausea and Dyspepsia:\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e Mild digestive discomfort.\u003c!--TgQPHd|||[]--\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/li\u003e\n\u003cli class=\"Z1qcYe\"\u003e\n\u003cspan class=\"iNqyIf\"\u003e\u003cstrong class=\"rQesXe MPyX\"\u003eHeadache:\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e Mild to moderate, typically resolving as the body adjusts.\u003c!--TgQPHd|||[]--\u003e\u003c\/span\u003e\u003cspan\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/li\u003e\n\u003c!--TgQPHd|||[]--\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"yhAwj\"\u003e\u003c!--TgQPHd|||[]--\u003e\u003c\/div\u003e\n\u003cdiv class=\"AdPoic\" role=\"heading\"\u003e\n\u003cstrong\u003eLong-Term or Rare Side Effects:\u003c\/strong\u003e\u003cspan\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/div\u003e\n\u003cul class=\"KsbFXc U6u95\"\u003e\n\u003cli class=\"Z1qcYe\"\u003e\n\u003cspan class=\"iNqyIf\"\u003e\u003cstrong class=\"rQesXe MPyX\"\u003eExcessive IGF-1 Elevation:\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e Prolonged, unmonitored therapy may push IGF-1 levels beyond normal physiological ranges, increasing the risk of acromegaly-like symptoms or systemic insulin resistance.\u003c!--TgQPHd|||[]--\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/li\u003e\n\u003cli class=\"Z1qcYe\"\u003e\n\u003cspan class=\"iNqyIf\"\u003e\u003cstrong class=\"rQesXe MPyX\"\u003eDevelopment of Anti-Drug Antibodies:\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e A small percentage of long-term users may develop antibodies to the peptide, which can reduce its clinical efficacy over time.\u003c!--TgQPHd|||[]--\u003e\u003c\/span\u003e\u003cspan\u003e\u003c\/span\u003e\u003c!--TgQPHd|||[]--\u003e\n\u003c\/li\u003e\n\u003c!--TgQPHd|||[]--\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"yhAwj\"\u003e\u003c!--TgQPHd|||[]--\u003e\u003c\/div\u003e\n\u003chr class=\"s6NV4e\"\u003e\n\u003cdiv class=\"n6owBd awi2gc\"\u003e\n\u003cstrong class=\"rQesXe MPyX\"\u003eDisclaimer:\u003c!--TgQPHd|||[]--\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cem class=\"zhvwWe\"\u003eThis information is for general knowledge and educational purposes only and does not constitute medical advice. Always consult with a qualified medical professional regarding any cosmetic or medical procedure.\u003c\/em\u003e\n\u003c\/div\u003e","brand":"All Peptides","offers":[{"title":"Default Title","offer_id":52729633767706,"sku":null,"price":1400.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0987\/8926\/1594\/files\/image_b997116d.jpg?v=1788896879","url":"https:\/\/allpeptides.co.za\/products\/tesamorelin","provider":"All Peptides","version":"1.0","type":"link"}